companydata.dkcompanydata.dk

DRUGRECURE ApS: Financial statements 2024

CVR: 29154406

Source: annual report 2024, Danish Business Authority

01/01/2024 – 31/12/2024

DRUGRECURE ApS (CVR 29154406) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK -227,524,000 and a net result of DKK -274,629,000 compared with DKK -133,501,000 the year before. Equity in the 2024 report amounted to DKK -1,077,717,000.

Gross Profit
DKK -227,524,000
Profit/Loss
DKK -274,629,000
Equity
DKK -1,077,717,000
Total Assets
DKK 27,503,000

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2024--227.5M-274.6M-1.1B-
2023--99.4M-133.5M-803.1M-
2022--66.1M-84.4M-669.6M-
2021--88.6M-140.2M-292M-
2020--121.7M-143M-151.8M-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Screen every Danish company

Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.

Try company screening

Events in 2024

DRUGRECURE ApS: The 2023 annual report is outJun 27, 2024

DRUGRECURE ApS has published its annual report for 2023. Gross profit came to DKK -99,396,000, and the net result was DKK -133,501,000.

About DRUGRECURE ApS

DRUGRECURE ApS is a Danish company of the type Anpartsselskab based in København K, founded in 2005. The company is registered under the industry Traditionelle, komplementære og alternative behandlingsformer. The company was previously named ApS KBUS 17 NR. 4495. The management consists of Danielle Marie Brown. The company is owned by Savara ApS. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -231,083,000 and a net result of DKK -282,428,000 compared with DKK -274,629,000 the year before. Equity in the 2025 report amounted to DKK -1,360,145,000.

Source: annual report 2025, Danish Business Authority